Crossmark Global Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.75M Sell
72,181
-90
-0.1% -$2.18K 0.03% 461
2025
Q1
$1.83M Sell
72,271
-3,001
-4% -$76K 0.03% 446
2024
Q4
$2M Hold
75,272
0.04% 398
2024
Q3
$2.18M Sell
75,272
-2,828
-4% -$81.8K 0.04% 392
2024
Q2
$2.19M Sell
78,100
-433
-0.6% -$12.1K 0.04% 383
2024
Q1
$2.18M Sell
78,533
-330
-0.4% -$9.16K 0.04% 401
2023
Q4
$2.27M Buy
78,863
+1,107
+1% +$31.9K 0.05% 367
2023
Q3
$2.58M Sell
77,756
-96,131
-55% -$3.19M 0.06% 331
2023
Q2
$6.27M Buy
173,887
+18,474
+12% +$666K 0.14% 186
2023
Q1
$6.34M Buy
155,413
+2,547
+2% +$104K 0.15% 177
2022
Q4
$7.83M Sell
152,866
-572
-0.4% -$29.3K 0.2% 139
2022
Q3
$6.71M Sell
153,438
-1,252
-0.8% -$54.8K 0.19% 138
2022
Q2
$8.11M Sell
154,690
-213
-0.1% -$11.2K 0.21% 124
2022
Q1
$8.02M Buy
154,903
+98,959
+177% +$5.12M 0.18% 151
2021
Q4
$3.3M Sell
55,944
-2,631
-4% -$155K 0.07% 266
2021
Q3
$2.52M Buy
58,575
+1,899
+3% +$81.7K 0.06% 325
2021
Q2
$2.22M Sell
56,676
-143,796
-72% -$5.63M 0.05% 349
2021
Q1
$7.26M Buy
200,472
+124,601
+164% +$4.51M 0.18% 139
2020
Q4
$2.79M Sell
75,871
-204,453
-73% -$7.53M 0.07% 297
2020
Q3
$9.76M Sell
280,324
-15,738
-5% -$548K 0.27% 89
2020
Q2
$9.19M Sell
296,062
-11,368
-4% -$353K 0.27% 89
2020
Q1
$9.52M Sell
307,430
-3,776
-1% -$117K 0.34% 78
2019
Q4
$11.6M Sell
311,206
-2,644
-0.8% -$98.3K 0.32% 83
2019
Q3
$10.7M Sell
313,850
-81,949
-21% -$2.79M 0.31% 80
2019
Q2
$16.3M Buy
395,799
+10,030
+3% +$412K 0.46% 43
2019
Q1
$15.5M Sell
385,769
-1,421
-0.4% -$57.3K 0.44% 42
2018
Q4
$16M Buy
387,190
+17,871
+5% +$740K 0.5% 36
2018
Q3
$15.4M Sell
369,319
-2,674
-0.7% -$112K 0.39% 48
2018
Q2
$12.8M Sell
371,993
-18,009
-5% -$620K 0.34% 55
2018
Q1
$13.1M Sell
390,002
-6,672
-2% -$225K 0.34% 59
2017
Q4
$13.6M Buy
396,674
+1,458
+0.4% +$50.1K 0.33% 63
2017
Q3
$13.4M Buy
+395,216
New +$13.4M 0.35% 57
2016
Q3
$13.4M Buy
+395,216
New +$13.4M 0.35% 57